JNJ · Full Picture

JOHNSON & JOHNSON — the full picture

Trailing window · 2026-05-11 to 2026-08-09

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Talc Litigation Settlement · Litigation & settlementsPriority 63
    1 forward row(s); quote_verified
    Johnson & Johnson has agreed to a $5.5 billion settlement to resolve tens of thousands of talc baby powder lawsuits.
  2. Accrued Legal and Regulatory · Regulatory action & investigationsPriority 61
    quote_verified
    Johnson & Johnson continues to navigate legal challenges related to its talc-based baby powder products.
  3. Capital Return Program · Buybacks & dividendsPriority 49
    quote_verified
    Johnson & Johnson has returned $85 billion to shareholders over the past five years through dividends and buybacks.
  4. Manufacturing capacity expansion · Supply chain & operationsPriority 48
    1 forward row(s); quote_verified
    Johnson and Johnson committed over a billion dollars to make more American-made contact lenses.
  5. Leadership Transition · Leadership & organizationPriority 35
    2 sources (news, press_release); quote_verified
    During her leadership Jennifer Taubert significantly grew the company's Innovative Medicine business to over $60 billion in annual revenue.

Threads by pillar

Costs & Margins Priority 48 · 1 thread

Capital & Balance Sheet Priority 49 · 1 thread

Legal, Regulatory & Policy Priority 66 · 2 threads

Management & Governance Priority 35 · 1 thread